PDF: Selective TYK2 Inhibition in the Treatment of Moderate to Severe Chronic Plaque Psoriasis

PDF Download: Moderate to severe chronic plaque psoriasis may be difficult to control using current therapies, which has led to development of a novel class of therapy, selective tyrosine kinase 2 (TYK2) inhibitors, to address this unmet need.